Harford Simon N.R.

Chief Financial OfficerAMICUS THERAPEUTICS, INC. (FOLD) · full profile →Form 4 · filed Apr 27, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Disposed to issuer(D)144K$14.50$2.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2026Disposed to issuer(D)189K0
Apr 27, 2026Disposed to issuer(D)99K0
Apr 27, 2026Disposed to issuer(D)151K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-182244) within minutes of acceptance. Every field above traces to the original document. Verify it directly: